Metosis AM 5mg/50mg Tablet is a combination antihypertensive medication containing Amlodipine 5mg and Metoprolol Succinate 50mg. Amlodipine, a dihydropyridine calcium channel blocker, acts by inhibiting calcium ion influx into vascular smooth muscle and cardiac muscle, resulting in vasodilation and reduced peripheral vascular resistance. Metoprolol Succinate, a selective beta-1 adrenergic receptor blocker, decreases heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and myocardial oxygen demand. This combination is indicated for the management of hypertension and angina pectoris, providing synergistic effects to improve blood pressure control and reduce cardiovascular risk. Metosis AM is particularly beneficial in patients requiring dual therapy for optimal blood pressure reduction or those with concomitant ischemic heart disease. The extended-release formulation of Metoprolol Succinate ensures stable plasma concentrations, promoting consistent therapeutic effects and improved patient compliance. Common adverse effects may include dizziness, fatigue, peripheral edema, and bradycardia. Caution is advised in patients with severe bradycardia, heart block, or decompensated heart failure. Regular monitoring of blood pressure, heart rate, and renal function is recommended during therapy. Metosis AM should be used under medical supervision, with dose adjustments based on clinical response and tolerability.